Nimotop for the prevention or treatment of ischemic and neurological deficits Nimotop is used for the prevention or treatment of ischemic and neurological deficits due to cerebral spasm after subarachnoid hemorrhage of aneurysm origin. Nimotop is available in the form of coated tablets. Box of 30 tablets (03 strips x 10 tablets).
Prescription drugs: Yes ( prescription drugs only )
Uses: Nimotop is manufactured by Bayer Schering Pharma AG - Germany, and the main ingredient is nimodipine.
Classification: Peripheral vasodilators and brain stimulants
Main ingredients: nimodipine
Dosage form: Tablets
Specifications: Box of 3 blisters x 10 tablets
Indications: ischemia, cerebral circulation disorders
Brand Origin: Germany
Producer: Bayer
Registration number: 31-4-96
Warning: Pregnant women, renal and hepatic failure, lactating women
Contraindications: Allergy to the drug
Country of manufacture: Germany
Note: This product is only sold when prescribed by a doctor, and all information on the site is for reference only.
Uses of Nimotop Bayer 30 tablets
Point
Nimotop is used in the following cases:
It is used after Nimotop infusion as an infusion solution, for the prevention or treatment of ischemia, and neurological deficits resulting from cerebral spasm followed by subarachnoid hemorrhage of aneurysm origin.
pharmacodynamics
Nimodipine, the main active component of Nimotop, is preferred, with anti-ischemic and vasoconstrictor activity. Vasoconstriction caused by various vasoactive substances (eg, serotonin, prostaglandins, histamine) or by blood and blood degradation products can be prevented or reduced. Nimodipine also has pharmacological and neuropsychological properties.
Studies in patients with severe cerebral vascular disorders have shown that nimodipine dilates cerebral vessels and increases cerebral blood flow. As a general rule, the perfusion increase in areas of the brain that were previously ischemic or damaged will be greater than in healthy areas. Nimodipine significantly reduces ischemic nerve damage in patients with subarachnoid hemorrhage and mortality.
